PharmaReports: Metabolic & Hormonal Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports featured here primarily focus on diabetes and obesity. Cachexia is also a focus of this channel as is metabolic dysfunction relating to pharmacological treatment (for example following treatment for HIV infection). Reports relating to hormonal disorders or diseases due to hormonal change (eg osteoporosis) can be featured here.
Showing results 51 - 100 of 123
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- HYPERCHOLESTEROLEMIA - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Infertility - Therapy Area Pipeline Report
- MENOPAUSAL SYMPTOMS - Therapy Area Pipeline Report
- Peripheral Neuropathy and Neuropathic Pain, 2008
- CONTRACEPTION - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Infertility
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The World Diabetes Market, 2006-2025
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential
- Diabetic Nephropathy - Prevalence and Therapeutic Potential
- Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?
- OTC Statins - The UK Experience
- Pipeline Insight: Diabetes Drug Delivery and Diagnostics - Towards the Non-invasive Revolution
- Commercial Perspectives: Anti-dyslipidemics - A tale of two launches
- Pipeline Insight: Osteoporosis - Intermittent Dosing and Multiple Indications Drive Market Growth
- Stakeholder Insight: Dyslipidemia - Titration versus Combination Therapy
- Commercial and Pipeline Perspectives: Obesity - Super-sized Epidemic
- Stakeholder Insight: Metabolic Syndrome - Ticking Time Bomb
- Stakeholder Insight: Insulin Use in Type 2 Diabetes - From Last Resort to Early Intervention
- Pipeline Insight: Non-insulin Antidiabetics - Three New Classes Compete for Market Control
- Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat
- Stakeholder Insight: Diabetic Neuropathic Pain - Market Success is Not Limited to Pregabalin
- Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
- The Women's Health Outlook to 2008: Market and pipeline analysis of major female disorders
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- Type II Diabetes: The 45+ Market in the United States for Drugs and Diagnostics
- Inhaled Insulin: A Market Briefing
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
- How to Conduct Clinical Trials in China
- Stakeholder Insight: Diabetes
- Launching Combination Products: Brand extension and franchise development strategies
- PAD Interventional Market Analysis: Angioplasty and Atherectomy
- Acute Limb Ischemia - A market of multiple therapies and multiple procedures
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development